Natural killer cells in antitumour adoptive cell immunotherapy
The University of Texas MD Anderson Cancer Center
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
732
total citations
- FWCI
- 69.26
- Percentile
- 100%
- References
- 255
Citations per year
Authors
3Topics & keywords
Topics
Keywords
- Chimeric antigen receptor
- Immunotherapy
- Immunology
- NK-92
- Cancer immunotherapy
- Interleukin 21
- Lymphokine-activated killer cell
- Cancer research
UN Sustainable Development Goals
- Industry, innovation and infrastructure
No related works found for this paper.
Funding
- AAAmerican Association for Cancer Research
- CPCancer Prevention and Research Institute of TexasAwards: RP160693, CA016672
- DFDeutsche ForschungsgemeinschaftAward: 464778766
- NINational Institutes of HealthAwards: P01CA148600, R01 CA211044-01, CA016672, CA211044-01, P50CA100632, P50CA127001, 5 P01CA148600-03, 1 R01 CA211044-01, P50CA100632-16, P01CA148600-03
- UOUniversity of Texas MD Anderson Cancer CenterAward: CA016672
- SUStand Up To CancerAward: SU2C-AACR-DT-29-19